PureTech Health PLC Director/PDMR Shareholding (8781K)
27 September 2016 - 4:01PM
UK Regulatory
TIDMPRTC
RNS Number : 8781K
PureTech Health PLC
27 September 2016
PDMR DEALING NOTIFICATION
1 Details of the person discharging managerial responsibilities/person closely associated
--- -----------------------------------------------------------------------------------------------------------------
a) Name Michael MacLean
--- -------------------------------------------------------- -------------------------------------------------------
2 Reason for the notification
--- -----------------------------------------------------------------------------------------------------------------
a) Position/status CFO
--- -------------------------------------------------------- -------------------------------------------------------
b) Initial notification/Amendment Initial notification
--- -------------------------------------------------------- -------------------------------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
--- -----------------------------------------------------------------------------------------------------------------
a) Name PureTech Health plc
--- -------------------------------------------------------- -------------------------------------------------------
b) LEI N/A
--- -------------------------------------------------------- -------------------------------------------------------
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
--- -----------------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of Restricted share unit ("RSU"), each
instrument of which entitles the holder to
Identification code one ordinary share of one pence
each in the capital of PureTech
Health plc ("Ordinary Share")
GB00BY2Z0H74
--- -------------------------------------------------------- -------------------------------------------------------
b) Nature of the transaction Award of RSUs by PureTech Health plc to Michael
MacLean pursuant to its Performance Share
Plan. The RSUs were granted for nil consideration.
The RSUs will vest in the following manner: 25% to
vest on 30 June 2017, and remaining 75%
shall vest in equal semi-annual instalments over the
three years following 18 January 2017;
provided that Michael MacLean continues to be employed
by PureTech Health plc on each such
vesting date.
Following vesting, Michael MacLean will be required to
make a payment of one pence per Ordinary
Share on settlement of the RSUs.
--- -------------------------------------------------------- -------------------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
---------- ----------
Nil 150,000
---------- ----------
--- -------------------------------------------------------- -------------------------------------------------------
d) Aggregated information- Aggregated volume
N/A
- Price
--- -------------------------------------------------------- -------------------------------------------------------
e) Date of the transaction 26 September 2016
--- -------------------------------------------------------- -------------------------------------------------------
f) Place of the transaction Outside a trading venue
--- -------------------------------------------------------- -------------------------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHFQLLLQKFXBBL
(END) Dow Jones Newswires
September 27, 2016 02:01 ET (06:01 GMT)
Puretech Health (LSE:PRTC)
Historical Stock Chart
From Apr 2024 to May 2024
Puretech Health (LSE:PRTC)
Historical Stock Chart
From May 2023 to May 2024